Miconazole%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520vaginal%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520pessary

## Miconazole Vaginal Pessary ### Overview Miconazole is an imidazole antifungal agent used to treat vaginal yeast infections (vulvovaginal candidiasis). The pessary formulation provides a localized, sustained release of the medication. ### Primary Indications Treatment of vulvovaginal candidiasis caused by *Candida* species. ### Adult Dosing * **Vaginal Pessary:** Insert one 100 mg pessary vaginally at bedtime for 7 consecutive nights. * Alternatively, some formulations may offer a 200 mg pessary inserted vaginally at bedtime for 3 consecutive nights. * Consult specific product labeling for available strengths and durations. ### Pediatric Dosing * Safety and efficacy in pediatric patients have not been established for the vaginal pessary formulation. Use in pediatric patients is generally not recommended. ### Dose Adjustments * No dose adjustment is typically required for renal or hepatic impairment due to minimal systemic absorption. ### Contraindications * Hypersensitivity to miconazole or any component of the formulation. ### Adverse Effects * **Common:** Vaginal burning, itching, irritation, pelvic cramps, lower abdominal pain. * **Less Common:** Headache, rash. ### Key Drug Interactions * Miconazole is a potent inhibitor of CYP3A4 and CYP2C9. Concomitant use with warfarin may increase the risk of bleeding. Close monitoring of INR is advised if coadministered. * Avoid concurrent use of other vaginal products (e.g., douches, tampons) during treatment. ### Monitoring * Monitor for signs and symptoms of vaginal candidiasis. * If symptoms persist or worsen after completing treatment, re-evaluate diagnosis and consider alternative therapy. * Monitor INR closely if patient is on warfarin therapy. ### Clinical Pearls * Treatment should be completed even if symptoms improve sooner. * Avoid sexual intercourse during treatment. * The pessary may weaken latex condoms and diaphragms, leading to failure. Advise patients to use alternative birth control methods during and for 72 hours after treatment. *** *This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional protocols before making clinical decisions.*